A study by National Taiwan University Hospital reveals that Hepatitis C patients remain at risk for liver cancer even after successful virus elimination. Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) face a twofold risk, which doubles again if they have severe fatty liver or diabetes. Experts emphasize the importance of monitoring metabolic indicators such as blood sugar and blood pressure post-cure.